Angiotensin-converting enzyme gene 2350 G/A polymorphism and susceptibility to atrial fibrillation in Han Chinese patients with essential hypertension

Clinics

Volumn 68, Issue 11, 2013, Pages 1428-1432

  Jiang, Min Hui ^a   Su, Ya Min ^a   Tang, Jian Zhong ^a   Shen, Yan Bo ^a   Deng, Xin Tao ^b   Yua, Ding Shan ^a   Wu, Jie ^c   Pan, Min ^a   Huang, Zhong Wei ^a  

^a NANTONG UNIVERSITY   (China)

^b Xinghua People's Hospital   (China)

^c Haimen People's Hospital   (China)

Author keywords

Angiotensin converting enzyme; Atrial fibrillation; China; Essential hypertension; Genetic polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

AGE; AGED; ARTICLE; ASIAN; BLOOD PRESSURE; BODY MASS; CHINA; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK FACTOR; SEX DIFFERENCE; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; BLOOD PRESSURE; BODY MASS INDEX; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; SEX FACTORS;

EID: 84887553231     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2013(11)08     Document Type: Article

References (38)

1. Pan M, Zhu JH, Jiang WP, Liu ZH, Li HM, Yu XH, et al. Inflammation: a possible pathogenic link to atrial fibrillation. Med Hypotheses. 2006;67(6):1305-1307. http://dx.doi.org/10.1016/j.mehy.2006.05.034.
2. Liu T, Korantzopoulos P, Xu G, Shehata M, Li D, Wang X, et al. Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and atrial fibrillation: a meta-analysis. Europace. 2011;13(3):346-354. http://dx.doi.org/10.1093/europace/euq407.
3. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369-2429.
4. Saritas A, Kandis H, Baltaci D, Erdem I. Paroxysmal atrial fibrillation and intermittent left bundle branch block: an unusual electrocardiographic presentation of mad honey poisoning. Clinics. 2011;66(9):1651-1653. http:// dx.doi.org/10.1590/S1807-59322011000900025.
5. Santos AC, Nobre MR, Nussbacher A, Rodrigues GH, Gebara OC, Azul JB, et al. Predictors of the risk of falls among elderly with chronic atrial fibrillation. Clinics. 2012;67(4):305-11. http://dx.doi.org/10.6061/clinics/ 2012(04)02.
6. Gu JY, Xu JH, Yu H, Yang YQ. Novel GATA5 loss-of-function mutations underlie familial atrial fibrillation. Clinics. 2012;67(12):1393-1399. http://dx. doi.org/10.6061/clinics/2012(12)08.
7. Li J, Song J, Jiang MH, Zheng JG, Gao SP, Zhu JH, et al. Interleukin-6 promoter polymorphisms and susceptibility to atrial fibrillation in elderly han chinese patients with essential hypertension. J Interferon Cytokine Res. 2012;32(11):542-547. http://dx.doi.org/10.1089/jir.2012.0033.
8. Hu D, Sun Y. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. J Am Coll Cardiol. 2008;52(10):865-868. http:// dx.doi.org/10.1016/j.jacc.2008.05.042.
9. Gao SP, Deng XT, Ge LJ, Luan H, Zheng JG, Chen C, et al. Is inflammation linked to thrombogenesis in atrial fibrillation. Int J Cardiol. 2011;149(2):260-261.
10. Mansur AP, Takada JY, Avakian SD, Strunz CM. Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation. Clinics. 2012;67(6):543-546. http://dx.doi.org/10.6061/clinics/2012(06)01.
11. Verdecchia P, Reboldi G, Gattobigio R, Bentivoglio M, Borgioni C, Angeli F, et al. Atrial fibrillation in hypertension: predictors and outcome. Hypertension. 2003;41(2):218-223. http://dx.doi.org/10.1161/01.HYP. 0000052830.02773.E4.
12. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic featuresof chronic atrial fibrillation: the Framingham study. NEnglJMed. 1982;306(17):1018-1022.
13. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98(5):476-484.
14. Rienstra M, Van Veldhuisen DJ, Crijns HJ, Van Gelder IC. Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial fibrillation in hypertensives: data of the RACE study. Eur Heart J. 2007;28(6):741-751. http://dx.doi.org/10.1093/eurheartj/ ehl436.
15. Goette A, Staack T, Rocken C, Arndt M, Geller JC, Huth C, et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol. 2000;35(6):1669-1677.http://dx.doi.org/10.1016/S0735-1097(00)00611-2.
16. Iravanian S, Dudley SC Jr. The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias. Heart Rhythm. 2008;5(6 Suppl):S12-7. http://dx.doi.org/10.1016/j.hrthm.2008.02.025.
17. Ehrlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J. 2006;27(5):512-518. http://dx.doi.org/10.1093/ eurheartj/ehi668.
18. Novo G, Guttilla D, Fazio G, Cooper D, Novo S. The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS. Br J Clin Pharmacol. 2008;66(3):345-351.
19. Pan M, Jiang MH, Wei MF, Liu ZH, Jiang WP, Geng HH, et al. Association of angiotensin-converting enzyme gene 2350G.A polymorphism with myocardial infarction in a Chinese population. Clin Appl Thromb Hemost. 2009;15(4):435-442. http://dx.doi.org/10.1177/1076029608316013.
20. Levy D, DeStefano AL, Larson MG, O'Donnell CJ, Lifton RP, Gavras H, et al. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension. 2000;36(4): 477-483. http://dx.doi.org/10.1161/01.HYP.36.4.477.
21. Zhu X, Bouzekri N, Southam L, Cooper RS, Adeyemo A, McKenzie CA, et al. Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet. 2001;68(5):1139-1148.
22. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572. http://dx.doi. org/10.1001/jama.289.19.2560.
23. Pan M, Zhu JH, Liu ZH, Jiang WP, Cui ZC, Yu XH, et al. Angiotensin-converting enzyme gene 2350 G/A polymorphism is associated with left ventricular hypertrophy but not essential hypertension. Hypertens Res. 2007;30(1):31-37. http://dx.doi.org/10.1291/hypres.30.31.
24. Liang S, Pan M, Hu N, Wu YY, Chen H, Zhu JH, et al. Association of angiotensin-converting enzyme gene 2350 G/A polymorphism with diabetic retinopathy in Chinese Han population. Mol Biol Rep. 2013;40(1):463-468. http://dx.doi.org/10.1007/s11033-012-2081-2.
25. Iwashima Y, Horio T, Kuroda S, Takishita S, Kawano Y. Influence of plasma aldosterone on left ventricular geometry and diastolic function in treated essential hypertension. Hypertens Res. 2002;25(1):49-56. http:// dx.doi.org/10.1291/hypres.25.49.
26. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994;330(23):1634-1638.
27. Kawamoto R, Kohara K, Tabara Y, Miki T. An interaction between systolic blood pressure and angiotensin-converting enzyme gene polymorphism on carotid atherosclerosis. Hypertens Res. 2002;25(6):875-880. http://dx.doi.org/10.1291/hypres.25.875.
28. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343-1346. http://dx.doi.org/10.1172/JCI114844.
29. Yamashita T, Hayami N, Ajiki K, Oikawa N, Sezaki K, Inoue M, et al. Is ACE gene polymorphism associated with lone atrial fibrillation. Jpn Heart J. 1997;38(5):637-641. http://dx.doi.org/10.1536/ihj.38.637.
30. Saeed M, Saleheen D, Siddiqui S, Khan A, Butt ZA, Frossard PM. Association of angiotensin converting enzyme gene polymorphisms with left ventricular hypertrophy. Hypertens Res. 2005;28(4):345-349. http://dx. doi.org/10.1291/hypres.28.345.
31. Alvi FM, Hasnain S. ACE I/D and G2350A polymorphisms in Pakistani hypertensive population of Punjab. Clin Exp Hypertens. 2009;31(5):471-480. http://dx.doi.org/10.1080/10641960902825479.
32. Vamsi UM, Swapna N, Reddy SS, Vishnupriya S, Tirunilai P. Risk of angiotensin-converting enzyme (ACE) gene I/D and g.2350G.A polymorphisms in causing susceptibility to essential hypertension. Asian Biomed (Res Rev News). 2012;6(2):255-264.
33. Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J, et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet. 2003;12(3):205-216. http://dx.doi.org/10.1093/hmg/ddg055.
34. Saeed M, Mekan SF, Rabbani MA, Arain FM, Arif M, Shaharyar S. Angiotensin converting enzyme (ACE) gene polymorphisms and lupus disease severity: a promising link. Ann Rheum Dis. 2005;64(1):164-165. http://dx.doi.org/10.1136/ard.2004.020834.
35. Vasudevan R, Ismail P, Stanslas J, Shamsudin N. Association of G2350A Polymorphism of Angiotensin Converting Enzyme Gene with Essential Hypertension and Type 2 Diabetes Mellitus in Malaysian Subjects. J Biol Sci. 2008;8(6):1045-1050.
36. Kehoe PG, Katzov H, Feuk L, Bennet AM, Johansson B, Wiman B, et al. Haplotypes extending across ACE are associated with Alzheimer's disease. Hum Mol Genet. 2003;12(8):859-867. http://dx.doi.org/10.1093/ hmg/ddg094.
37. Firouzabadi N, Tajik N, Shafiei M, Ebrahimi SA, Bakhshandeh H. Interaction of A-240T and A2350G related genotypes of angiotensin-converting enzyme (ACE) is associated with decreased serum ACE activity and blood pressure in a healthy Iranian population. Eur J Pharmacol. 2011;668(1-2):241-247.
38. Zhu TN, Pan JQ, Shen ZJ, Zhao YQ, Shen T. Gene polymorphisms of rennin-angiotensin system and coronary artery thrombosis disease. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004;12(5):674-679.